Human platelet glycoproteins Ilb (GPIIb) and Illa (GPIIIa) form the subunits of the Ca2+-dependent heterodimer GPIIb/IIIa, which belongs to the integrin family of phylogenetically related receptors mediating a wide variety of cell-cell and cell-substratum interactions. GPIIb/IIIa plays a central role in haemostasis as a receptor for fibrinogen and other adhesive proteins at the surface of activated platelets. The covalent structure of the subunits is largely known; however, the tertiary and quaternary structures of the heterodimer remain to be determined. To this end, our approach consisted of limited proteolysis of the isolated heterodimer with proteinases of different specificities, followed by protein-chemical and immunochemical analyses of the peptide fragments within each isolated proteolytic product. From the information obtained, we have drawn a rudimentary map which outlines the demarcation of compact domains and the subunit peptide stretches carrying the sequences putatively involved in intrachain, intrasubunit and intersubunit non-covalent connectivity in the heterodimer.
INTRODUCTION
Glycoprotein Ilb (GPIIb or aIIb; 136 kDa) is a two-chain bitopic membrane protein which, together with the single-chain bitopic membrane glycoprotein Illa (GPIIIa or /33; 92 kDa) (Phillips & Agin, 1977; Calvete & Gonzalez-Rodriguez, 1986; Usobiaga et al., 1987) , forms the Ca2+-dependent heterodimer GPIIb/IIIa at the surface of the human platelet (Kunicki et al., 1981; Rivas & Gonzalez-Rodriguez, 1991) . GPIIb/IIIa, also known as integrin alIbi3, is the major intrinsic protein at the platelet plasma membrane, where it serves as the inducible receptor for fibrinogen and other adhesive proteins, and plays a central role in platelet aggregation and adhesion . GPIIb/IIIa is the integrin that has been most extensively characterized, and together with the vitronectin receptor (integrin CAJ3) forms the #3 integrin subfamily . The complete amino acid sequences of GPIIb and GPIIIa have been derived by cDNA cloning (Fitzgerald et al., 1987; Poncz et al., 1987) , and the genomic organization of both genes has been established (Heidenreich et al., 1990; Lanza et al., 1990; Zimrin et al., 1990 ).
Much of the covalent structure of mature GPIIb/IIIa is known (Calvete et al., 1989 (Calvete et al., , 1990 (Calvete et al., , 1991b , and its topography is being gradually revealed (D'Souza et al., 1988 (D'Souza et al., , 1990 (D'Souza et al., , 1991 Calvete et al., 1988 Calvete et al., , 1991a Lam et al., 1989; Loftus et al., 1990; Charo et al., 1991; J. J. Calvete, W. Schafer, K. Mann, A. Henschen & J. Gonzilez-Rodriguez, unpublished work) . However, the tertiary and quaternary structures of the heterodimer remain to be determined. To this end, our approach here consists of limited proteolysis of the isolated heterodimer in non-denaturing conditions, followed by protein-chemical and immunochemical analyses of the peptide fragments within the isolated proteolytic products. The information obtained was used to draw a rudimentary map which outlines the demarcation of proteinaseresistant and/or compact domains and the subunit sequences involved in putative intrachain, intrasubunit and intersubunit non-covalent connectivity in the heterodimer in solution.
MATERIALS AND METHODS Materials
1-Chloro-4-phenyl-3-L-tosylamidobutan-2-one (Tos-PheAbbreviations used: GPIIb, GPIIIa and GPIIb/IIIa, glycoproteins IIb, Illa and the heterodimer formed between them; GPIIbH and GPIIbL, the heavy (H) and the light (L) chains of GPIIb; GPIIbL1 and GPIIbL2, the large and the small forms of GPIIbL; Tos-Phe-CH2Cl, l-chloro-4-phenyl-3-L-tosylamidobutan-2-one ('TPCK').
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CH2Cl; TPCK)-treated trypsin, a-chymotrypsin and n-octyl /3-Dglucopyranoside (>98 % pure) were from Sigma (St. Louis, MO, U.S.A.); endoproteinase Glu-C (Staphylococcus aureus V8 proteinase) was from Worthington (Freehold, NJ, U.S.A.); TSK-SW 2000 and 3000 (7.5 mm x 600 mm) size-exclusion columns were from LKB (Bromma, Sweden) ; N-hydroxylsuccinimidyl-4-azidosalicylic acid was from Pierce (Rockford, IL, U.S.A.). GPIIb/IIIa was prepared as described previously (Rivas et al., 1991a) . The other chemicals and biochemicals were of analytical or chromatographic grade.
Analytical methods
Amino acid analyses were performed with a Biotronik amino acid analyser after sample hydrolysis at 110°C in 6 M-HCI for 24 h. SDS/PAGE was carried out according to Laemmli (1970) . Immunoelectroblotting after gel electrophoresis and competitive enzyme immunoassay were done as described previously (Calvete et al., 1991a,c) GPIIIa (P23-7, P37 and P40) whose epitopes have been precisely assigned in the amino acid sequence of these glycoproteins (Calvete et al., 1991a,c replacing CaCl2 by 1 mM-EDTA. The isolated proteolytic products were designated by the initial of the proteinase used for digestion (T for trypsin, C for chymotrypsin and V for V8 endoproteinase) followed by the apparent molecular mass (kDa) determined by size-exclusion chromatography. The isolated proteolytic products were subjected to amino acid, N-terminal sequence and immunochemical analyses, and afterwards were dialysed overnight against Milli-Q water, freezedried and dissolved in 70% (v/v) formic acid. The dissociated peptide fragments were isolated by reverse-phase h.p.l.c. on a C4
(pore size 30 nm; particle size 10 /um) Vydac column (25 cm x 0.4 cm) equilibrated in a mixture of 0.1 % (v/v) trifluoroacetic acid in water (A) and 0.1 % trifluoroacetic acid in acetonitrile (B) (1000% A/0 % B) and eluted at 1 ml/min. Elution was isocratic for 5 min, followed by a linear gradient up to 70 % B in 70 min. The isolated peptides were subjected to amino acid, N-terminal sequence and immunochemical analyses. size-exclusion chromatography as described above. Cross-linking of the synthetic peptides to the isolated proteolytic products was estimated from the absorption at 280 and 530 nm, using the following extinction coefficients: £280 1. i ml * mg-' cm-' for protein content and 85000 M-l cm-' for eosin (Usobiaga et al., 1987) .
Hydropathy plots
Hydropathic profiles of peptide sequence stretches were generated using the hydrophilic/hydrophobic scale of Kyte & Doolittle (1982) . The GPIIb and GPIIIa amino acid sequences used were those derived by cDNA cloning (Heidenreich et al., 1990; Zimrin et al., 1990) . The search for GPIIIa sequence stretches that are hydropathically complementary to selected GPIIb sequence stretches was carried out by the method of Blalock & Smith (1984) .
RESULTS
Pattern of fragmentation of GPIIb/IIIa by tryptic digestion When GPIIb/IIla in digestion buffer was cleaved with TosPhe-CH2CI-treated trypsin at an enzyme/substrate ratio of 1:250 (w/w) for 1 h at 37°C (see the Materials and methods section), five fractions were separated by size-exclusion chromatography on a TSK-SW 3000 column (Fig. la) . These were designated according to their apparent molecular mass (kDa), as follows: T-100, T-60, T-45, T-20 and T-18. Each fraction was rechromatographed on either a TSK-SW 3000 or a TSK-SW 2000 column, depending on its molecular mass, in the presence of 0.1 mM-Ca2+ or of 1 mM-EDTA after incubation in 10 mM-EDTA at 37 'C. It was found that all of the fractions were homogeneous in size and the proteolytic product(s) within each of them were stable, both with and without Ca2t. Amino acid, N-terminal sequence and immunochemical analyses of each fraction allowed us to assign their subunit origin and, to a certain extent, the size of the proteolytic fragments which constituted each of them, as well as establishing that each fraction contained a single proteolytic product. Thus it was found that T-100, T-20 and T-18 were primary proteolytic products of GPIIb/IIIa, whereas T-60 and T-45 were secondary products of T-100. It was also found that both T-100 and T-20 contained peptide fragments derived from GPIIbH, GPIIbL and GPIIIa, that T-60 contained fragments from both GPIIbL and GPIIIa, and that the T-45 and T-18 products contained fragments from only GPIIIa and GPIIbH respectively. Moreover, T-100 contained only the epitopes for antibodies P23 7 [GPIIIa-(1 14-122)] and P37 Size-exclusion chromatography of each proteolytic product, in buffer where n-octyl /3-D-glucopyranoside was replaced by SDS, revealed that the constituent fragments of each proteolytic product were non-covalently associated. Furthermore, solubilization of each proteolytic product in 70 % formic acid, followed by separation of the constituent fragments by reverse-phase h.p.l.c. (Fig. 2) and amino-acid, N-terminal sequence and immunochemical analyses of the isolated peptides, confirmed the non-covalent nature of the associations and the lack of disulphide bond exchange among the fragments within each proteolytic product, and provided additional data for a more precise assignment of the size of each peptide fragment (Tables 1 and 2 ). In two out of five experiments, the peptide stretch GPIIbL2-(125-137) was found associated with the T-18 product, but in the Vol. 282 T-100 GPIIIa [684] [685] [686] [687] [688] [689] [690] [691] [692] [693] [694] other experiments this isolated products.
peptide was not found in any of the Tryptic digestion of GPIIb/IIIa for only 15-30 min provided a fragmentation pattern similar to that described above for a 1 h digestion, except that part of GPIIb/IIIa remained undegraded, the peptide bond in GPIIbH between residues 479 and 480 was still maintained, and the T-60 and T-45 products were minor species. On the other hand, after 2 h of tryptic digestion T-100 itself represented only a minor fraction, whereas the secondary products T-60 and T-45 were major species, being the peptide GPIIbH 91-139, within the T-20 kDa product, cleaved between residues 118 and 119, but the tryptic products were maintained together by the GPIIb 107-130 disulphide bond.
Pattern of fragmentation of GPIIb/IIIa on digestion with V8 endoproteinase Cleavage of GPIIb/IIIa with V8 endoproteinase was carried out at an enzyme/substrate ratio of 1:100 (w/w) for 5 or 24 h at 37 'C. The 5 h digestion products were separated by sizeexclusion chromatography into two major fractions, designated V-100 and V-20. The 24 h digestion products were also distributed in two major fractions, designated V-60 and V-16 (Fig. lb) . All of these fractions were homogeneous in size and were stable, both with and without Ca2", upon size-exclusion rechromatography. Amino-acid, N-terminal sequence and immunochemical analyses of the undissociated fractions and of their constituent peptides, separated by reverse-phase h.p.l.c. after dissociation in ) and eluted at 1 ml/min, first isocratically for 5 min, followed by a linear gradient up to 70 %0 B in 70 min.
70 % formic acid (see the Materials and methods section), allowed us to assign the subunit and chain origins and the sizes of the proteolytic fragments within each fraction, and to establish that each fraction contained a single proteolytic product, which is produced by non-covalent association of peptides (Tables 2 and  3 ). It was found that V-100 and V-20 were the primary proteolytic products of GPIIb/IIIa, whereas V-60 and V-16 were secondary products of V-100 and V-20 respectively. It was also found that V-100 contained peptide fragments from GPIIbH, GPIIbL and GPIIIa and the epitopes for the antibodies P237, P37 and M5 ], V-60 contained sequences from GPIIbL and GPIIIa, V-20 contained sequences from GPIIbH and GPIIbL and the epitopes for the antibodies M1 and M6 ], and V-16 contained peptide fragments only from GPIIbH and the epitope for antibody M6.
Pattern of fragmentation of GPIIb/IIIa on chymotryptic digestion Digestion of GPIIb/IIIa with chymotrypsin was carried out at an enzyme/substrate ratio of 1:250 (w/w) for 3.5 and 24 h. The 3.5 h digestion products were separated by size-exclusion chromatography into three main fractions, designated C-90, C-60 and C-20 (where numbers denote molecular mass in kDa). The 24 h products were distributed in three chromatographic fractions, designated C-70, C-45 and C-18 (Fig. 1c) . All of these fractions, as with the tryptic and V8 endoproteinase fractions, were both homogeneous in size and stable, with and without Ca2 , upon size-exclusion rechromatography. Amino-acid, N-terminal sequence and immunochemical analyses of each undissociated fraction and of their constituent peptides, separated by reversephase h.p.l.c. after solubilization in 70 % formic acid, allowed us to assign the subunit and chain origins and the sizes of the proteolytic fragments within each fraction, as well as establishing that each size-exclusion fraction contained a single proteolytic product (Tables 2 and 4) . Thus it was found that C-90 and C-20 were primary chymotryptic products of GPIIb/IIIa, and C-70, C-60, C-45 and C-18 were secondary products of C-90. It was also found that C-45 and C-18 contained peptide fragments from only GPIIIa and GPIIbH respectively, C-20 contained sequences from GPIIbH and GPIIbL and the epitopes for the antibody M1, C-70 and C-60 contained sequences from both GPIIbL and GPIIIa, and C-90 was the only product which contained peptide fragments from GPIIbH, GPIIbL and GPIIIa, and also carried the epitopes for antibodies M2 ], M5 and M6.
Photocross-linking of the RGD and KQAGDV peptides to the digestion products of GPIIb/IIIa A sample of each GPIIb/IIIa digestion mixture, after stopping proteolysis at the desired time by addition of phenylmethanesulphonyl fluoride, was incubated with the derivatized synthetic peptides for I h at 37°C, followed by u.v. irradiation (see the Materials and methods section). The reaction mixtures were then subjected to size-exclusion chromatography to isolate Table 2 . Distribution of the epitopes for a set of GPIIb-and GPIIIa-specific monoclonal antibodies (mAbs) among the digestion products of GPIIb/IIIa Digestion products were isolated as shown in Fig. 1 . Peptide compositions are given in Tables 1, 3 
V-100 GPIIIa
GPIIbL,
the different digestion products of GPIIb/IIIa described above, to establish the peptide distribution present and to quantify the peptide cross-linking. Eosin was not found in any of the chromatographic fractions, except in those containing undegraded GPIIb/IIIa. Therefore no photocross-linking of the RGD and KQAGDV peptides to the proteolytic products had taken place, in spite of the fact that some of the products still maintained, partially or totally intact, peptide sequences which had previously been found to be photocross-linked to intact GPIIb/IIIa (Tables 1, 3 
tation patterns obtained with proteinases of different specificities, the topography of the protein and the intrachain, intrasubunit and intersubunit non-covalent connections. This information lays down the basis for further work, leading to a more precise demarcation of structural and functional domains. This was our approach in the present work on the structure of the isolated GPIIb/IIIa heterodimer in non-denaturing conditions. The patterns of proteolytic cleavage of GPIIb/IIIa indicate the presence of particular regions along the amino acid sequences of GPIIIa, GPIIbH and GPIIbL which show either high susceptibility or high resistance to proteolysis by trypsin, chymotrypsin and V8 endoproteinase. Thus the major susceptible regions of GPIIIa are within the sequences of GPIIIa comprising residues 100-150, 308-324 and 689-694. The first two regions are located within the so-called ligand-binding domain, identified previously in isolated GPIIIa, and the other region is found immediately adjacent to the single transmembrane sequence of GPIIIa (Calvete et al., 1991b Scheme 1. Outline of the cleavage points and peptide fragments within the GPIIb/IIIa proteolytic products isolated in Fig. 1 Peptide compositions are given in Tables 1, 3 and 4. The proteolytic products are designated by the initial of the proteinase used for GPIIb/IIIa digestion (T, trypsin; V, V8 endoproteinase; C, chymotrypsin) followed by the apparent molecular mass (in kDa) determined by size-exclusion chromatography. Peptide fragments and interpeptide disulphide bridges are represented by bold and thin lines respectively. Numbers represent the positions of the N-and C-terminal ends of the peptide fragments in the amino acid sequences of GPIIIa, GPIIbH and GPIIbL2 (Heidenreich et al., 1990; Zimrin et al., 1990 ).
(residues 1-52) and the core (residues 423-622), which are disulphide-bonded between themselves (Calvete et al., 1991b) . GPIIbL has two highly proteolysis-susceptible regions: GPIIbL2-(24-27), which determines the location of the N-terminal end of GPIIbL in those fragments carrying GPIIbH residue Cys-826 (Calvete et al., 1989), and GPIIbL2-(75-89) , which is adjacent to the transmembrane segment of GPIIbL. Finally, and contrary to the case with GPIIIa, GPIIbH is highly susceptible to proteolysis all along its sequence, in good agreement with previous structural and immunochemical studies (Calvete et al., 1991 a 486-553) and This suggests that GPIIbL as well as GPIIbH contributes to the subunit interface (Lam et al., 1989; Calvete et al., 1991la) . The first putative subunit interface is easily inferred from the peptide composition of the T-20 product (Table 1 and Scheme 1). Although the actual pattern of peptide interaction within this product is still unknown, some information is available. Thus intrachain and/or intrasubunit interactions between GPIIbH-(91-139) and and/or GPIIbL2-(1-26) can be inferred from the presence of these sequences, in all or most of their length, in other products such as C-20 and V-20 (Scheme 1). Furthermore, the lack of any GPIIIa sequence and of the GPIIbH-(780-8 14) stretch in the latter two products points to an interaction between the GPIIIa-(2l7-235)-S-S-(269-298) and the GPIIbH- (780-8 14) sequences. On the other hand, hydropathy plots show a high hydropathic complementarity (pairing of hydrophobic and hydrophilic residues) between GPIIIa-(225-235) and (Fig. 3a) and between GPIIbH-(103-110) and GPlIbL2-(7-14) (Fig. 3b) ., If all these hypotheses prove to be correct, then the pattern of peptide interactions within the T-20 product (and probably within GPIIb/Illa) would be GPIIIa-(225-235)/GPIIbH-(783-793) and GPIIbH-(103-1 l0)/GPIIbL2-(7-l4).
This pattern of peptide interactions agrees with previous immunochemical and molecular genetic studies. Thus an antiserum against the GPIIIa-(217-23 1) stretch did not recognize its epitope in the heterodimer (Cook et al., 1992) . On the other hand, an epitope on the C-terminus of the ax-subunit precursor of Mac-i, whose equivalent localization in GPIIb would be within the GPIIbH-74l-GPIIbL2-28 stretch, becomes hidden in the heterodimer (Arnaout et al., 1988) .
The second subunit interface may be inferred by comparison of the peptide compositions of the T-60 and C-60 products with those of the T-45 and C-45 products respectively (Tables 1, 3 and 4; Scheme 1). The latter two productsi lack the GPIIIa-(403-422) and GPIIbL -(30-75) sequences; we th'us propose that these two sequences form part of the, interface between GfPIIb and GPIlIa in the heterodimer. Alternativ'ely, the G.PIIbL -(30-75) sequence could be interacting with-other regions, of GPIIIa which are affected by the structural change induced in the remains of GPIIIa (the 45 kDa products) by the cleavages within the GPIlIa-(410-415) stretch, or the GPIIbL2-(07)sqence Itsl col be extensively degraded at this late stage of proteolysis of GPIIb/Illa. However, the high hydropathic complementarity found between the GPIIIa-(406-413) and GPIIbL2-(29-36) sequences (Fig. 3c) favours the first interpretation. Moreover, since the GPIIIa-(41 5-428) stretch is missing from the C-45 product, part of this stretch may also contribute to the second subunit interface.
The sequences GPIla-(324-365), GPIIbH-(486-553) and were present in the T-100, C-90 and V-100 products of GPIIb/IIIa digestion, but were not found in the T-60, C-60 or V-60 products (Tables 1, 3 and 4; Scheme 1). We therefore propose that the GPIIIa-(324-365) sequence is involved, together with GPIIbH-(486-553) and/or GPIIbH-(696-734), in the subunit interface of the heterodimer, in good agreement with previous structural studies of GPIIb/IIIa in whole platelets (Calvete et al., 1991a ). An alternative interpretation, based on and intersuhunit non-covalent connectivity in the GPIIb/IlIa heterodimer in solution (a) GPIIbH-(783-793) (TYELHNNGPGT) (@) and (AIMQATVCDEK) (L1); (b) GPIIbH-(103-1 10) (VIVACAPW) (@) and (PEQPSRLQ) (El) ; (c) GPIIbL2-(29-36) (RAMVTVLA) (@) and 13 ) (CEQEKEKS) ([LI); (d) (PGTTVGVLSM) (0) and GPIIbH-(702-71 1) (AMLVSUGNLE) LI); (e) (VLQLIVDAY) (0) and (HNIPQKISL) (El); (f) GPIIIbH-(679-688) (ENETRVVLCE) (0) and GPIIbH-(598-607) (IVLDCGEDDV) (LI); (g) GPIIbH-(4-1 1) (DPVQLTFY) (@) and GPIIbH-(630-637) (VLELQMDA) (El).
Vol. 282 the structural changes that are proteolytically induced in the remains of both GPIIbH (C-18 and V-16) and GPIIIa (the 60 kDa products) could lead us to other, as yet unidentified, sequences that are involved in the intersubunit interactions taking place in the 90 and 100 kDa products. Hydropathy plots of the proposed interacting sequences identified a high hydropathic complementarity between the GPIIIa-(328-337) and sequences (Fig. 3d) and between the GPIIIa-(342-350) and sequences (Fig. 3e) , which supports our first proposition.
GPIIbH sequences putatively involved in intrachain contacts
The sequences found in the V-16 product (Table 3 ; Scheme 1) must form a compact intrachain domain in the GPIIb/IIIa heterodimer. Although the actual interactions between these peptides cannot be inferred from the information available at present, the high hydropathic complementarity found between the GPIIbH-(598-607) and GPIIbH-(679-688) sequences (Fig. 3J ) points to the likelihood of a specific interaction between these two sequences.
The T-18 product (Table 1 ; Scheme 1) contains the first 32 residues of GPIIbH and sequences found in V-16 extended six residues upstream, to residue 694 of GPIIbH, but lacking the GPIIbH-(662-671) and -(678-683) stretches (Scheme 1). The structure of this product confirms the idea that the GPIIbH-(595-690) sequence forms a well-defined domain which remains intact independently of cleavage at different points within this sequence by the three proteases (T-18, C-18 and V-16) . Also, the composition of the T-18 product suggests that the N-terminal end of the GPIIbH chain is folded against the GPIIbH-(595-690) domain. Further support for this interpretation comes from the high hydropathic complementarity found between the GPIIbH-(4-11) and GPIIbH-(630-637) sequences, as shown in Fig. 3(g) .
The V-20 product comprises the sequences found in V-16, but without cleavage at residues 629, 633 and 647 of GPIIbH, and two additional fragments from both ends of GPIIbH, i.e. and , disulphide-bonded to GPIIbL2-(1-23) (Table 3 ; Scheme 1). We have already discussed the interaction of the sequence with the Nterminal stretch of GPIIbH and the association of the N-terminal end of GPIIbH with the GPIIbH-(595-690) region. Therefore the GPIIbH-(1-136) stretch most probably interacts at its N-terminal end with the GPIIbH-(595-690) region and at its C-terminal end with .
Further proof that the GPIIbH-(600-700) sequence forms a packed domain is given by the C-18 product, which comprises the GPIIbH-(599-703) sequence (but lacking residues 646-672), and two additional fragments, and (Table 4 ; Scheme 1). This suggests that the first Ca2+-binding site of GPIIbH (residues 243-254) may be folded against the GPIIbH-(600-700) domain, together with the N-terminal end of GPIIbH, although there is no indication of the actual sequences involved in this interaction.
Finally, the C-20 product contains, among others, the GPIIbH-(97-143) and GPIIbH-(815-839)-S-S-GPIIbL2-{1-24) sequence stretches, in agreement with inferences made above from the structural analysis of other proteolytic products. The other fragments present in this product are and -(420-485). If we take into consideration that the V-100 product ( (Rivas & Gonzalez-Rodriguez, 1991) . This may be due to destruction of the high-affinity Ca2+-binding site, either directly by cleavage or indirectly by the structural change subsequent to proteolysis. Alternatively, the proteolytic cleavages could stabilize the subunit interface structures and make them Ca2+-independent, as occurs at low temperature (Rivas et al., 1992 (Calvete et al. 1989 (Calvete et al. , 1991a Niewiarowski et Gonzalez-Rodriguez, unpublished work) . (5) The three main proteolysis-susceptible regions of GPIIIa in the heterodimer allowed us to confirm the existence of two proteolysis-resistant disulphide-bond-rich domains, the N-terminal domain residues (1-52) and the core (residues 423-622), which are disulphidebonded between themselves, and a highly proteolysis-susceptible region, known as the ligand-binding domain (residues 101-400).
These three domains had already been identified in isolated GPIIIa in solution (Beer and Coller 1991 ; Calvete et al., 1991b,c) . (6) The extracellular end of the single transmembrane segment of both GPIIIa and GPIIbL, the N-and C-termini of GPIIbH and the N-terminus of GPlIbL in the heterodimer in solution are easily accessible to the three proteinases used in the present study. (7) The following pairs of sequences were found to be putatively involved in the subunit interface of the heterodimer: (a) GPIIIa-(217-235)-S-S-GPIIIa-(262-298)/GPIIbH-(780-836), (b) GPIIIa-(324-366)/GPIIbH-(486-553) and GPIIbH-(696-734), and (c) GPIIIa-(403-421)/GPIIbL2-(30-75). It is remarkable that these putative intersubunit regions correspond well to exon boundaries within the gene structure of GPIIb and GPIIIa (Heidenreich et al., 1990; Zimrin et al., 1990) . Thus sequences within GPIIIa exons IV-V (residues 18() 287), Vll-VIII (residues 320-396) and the N-terminal part of exon IX GPIIb and GPIIIa (Poncz et al., 1987; Fitzgerald et al., 1987; Calvete et al., 1989 Calvete et al., , 1991b . (8) The pair of sequences GPIIbH-(97-113)/GPIIbL2-(l-23) was found to be putatively involved in intrasubunit interactions in GPIIb. Based on all of these features, a rudimentary connectivity map for the GPIIb/IIIa heterodimer is given in Fig. 4 . It is immediately evident that this map does not agree with the current accommodation of the primary structure of GPIIb and GPIIIa within the head/two-tails image of GPIIb/IIIa in solution seen by electron microscopy (Carrell et al., 1985; Rivas et al., 1991b) .
Thus, according to this interpretation, the tips of the two tails would represent the C-terminal regions of GPIIIa and GPIIbL respectively, and the N-terminal halves of GPIIIa and GPIIbH would represent the globular head ). However, the present findings suggest that the N-terminal region
